Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Anna Bucsics, Brian Godman, Thomas Burkhardt, Manuela Schmitzer & Rickard E Malmström. (2012) Influence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 12:6, pages 809-819.
Read now
Read now
Vanda Markovic-Pekovic, Ranko Škrbić, Brian Godman & Lars L Gustafsson. (2012) Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions. Expert Review of Pharmacoeconomics & Outcomes Research 12:5, pages 661-671.
Read now
Read now
Mohammed Abuelkhair, Shajahan Abdu, Brian Godman, Sahar Fahmy, Rickard E Malmström & Lars L Gustafsson. (2012) Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi. Expert Review of Pharmacoeconomics & Outcomes Research 12:1, pages 115-124.
Read now
Read now
Luka Vončina, Tihomir Strizrep, Brian Godman, Marion Bennie, Iain Bishop, Stephen Campbell, Vera Vlahović-Palčevski & Lars L Gustafsson. (2011) Influence of demand-side measures to enhance renin–angiotensin prescribing efficiency in Europe: implications for the future. Expert Review of Pharmacoeconomics & Outcomes Research 11:4, pages 469-479.
Read now
Read now
Kristina Garuoliene, Brian Godman, Jolanta Gulbinovič, Björn Wettermark & Alan Haycox. (2011) European countries with small populations can obtain low prices for drugs: Lithuania as a case history. Expert Review of Pharmacoeconomics & Outcomes Research 11:3, pages 343-349.
Read now
Read now
Brian Godman, Solveig Sakshaug, Christian Berg, Björn Wettermark & Alan Haycox. (2011) Combination of prescribing restrictions and policies to engineer low prices to reduce reimbursement costs. Expert Review of Pharmacoeconomics & Outcomes Research 11:1, pages 121-129.
Read now
Read now
Articles from other publishers (8)
Brian Godman, Joseph Fadare, Hye-Young Kwon, Carolina Zampirolli Dias, Amanj Kurdi, Isabella Piassi Dias Godói, Dan Kibuule, Iris Hoxha, Sylvia Opanga, Zikria Saleem, Tomasz Bochenek, Vanda Marković-Peković, Ileana Mardare, Aubrey C Kalungia, Stephen Campbell, Eleonora Allocati, Alice Pisana, Antony P Martin & Johanna C Meyer. (2021) Evidence-based public policy making for medicines across countries: findings and implications for the future. Journal of Comparative Effectiveness Research 10:12, pages 1019-1052.
Crossref
Crossref
Rondineli Mendes da Silva, Gabriela Costa Chaves, Luisa Arueira Chaves, Mônica Rodrigues Campos, Vera Lucia Luiza, Andréa Dâmaso Bertoldi, Dennis Ross-Degnan & Isabel Cristina Martins Emmerick. (2017) Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines. Ciência & Saúde Coletiva 22:8, pages 2501-2512.
Crossref
Crossref
Ulrik Hesse, Brian Godman, Max Petzold, Andrew Martin & Rickard E. Malmström. (2013) Impact of Delisting ARBs, Apart from Losartan, on ARB Utilisation Patterns in Denmark: Implications for Other Countries. Applied Health Economics and Health Policy 11:6, pages 677-685.
Crossref
Crossref
Steven Simoens, Kristien De Bruyn, Jamilette Miranda, Marion Bennie, Rickard E. Malmström & Brian Godman. (2013) Measures to enhance angiotensin-receptor blocker prescribing efficiency in Belgium following generic losartan: impact and implications for the future. Journal of Pharmaceutical Health Services Research 4:3, pages 173-181.
Crossref
Crossref
B. Godman, B. Wettermark, J. Miranda, M. Bennie, A. Martin & R. E. Malmström. (2013) Influence of multiple initiatives in Sweden to enhance ARB prescribing efficiency following generic losartan; findings and implications for other countries. International Journal of Clinical Practice 67:9, pages 853-862.
Crossref
Crossref
Marija KalabaBrian Godman, Aleksandar Vuksanović, Marion Bennie & Richard E Malmström. (2012) Possible ways to enhance renin–angiotensin prescribing efficiency: Republic of Serbia as a case history?. Journal of Comparative Effectiveness Research 1:6, pages 539-549.
Crossref
Crossref
Magda Wladysiuk, Aleksander Araszkiewicz, Brian Godman, Katarzyna Szabert, Corrado Barbui & Alan Haycox. (2011) Influence of Patient Co-Payments on Atypical Antipsychotic Choice in Poland. Applied Health Economics and Health Policy 9:2, pages 101-110.
Crossref
Crossref
Brian Godman, William Shrank, Bjorn Wettermark, Morten Andersen, Iain Bishop, Thomas Burkhardt, Kristina Garuolienè, Marija Kalaba, Ott Laius, Roberta Joppi, Catherine Sermet, Ulrich Schwabe, Inês Teixeira, F. Cankat Tulunay, Kamila Wendykowska, Corinne Zara & Lars L Gustafsson. (2010) Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?. Pharmaceuticals 3:8, pages 2470-2494.
Crossref
Crossref